Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.91M Buy
22,176
+512
+2% +$42.6K 0.07% 193
2026
Q2
$1.46M Buy
21,664
+2,688
+14% +$179K 0.05% 230
2026
Q1
$1.19M Buy
18,976
+3,858
+26% +$269K 0.08% 214
2025
Q4
$1M Buy
15,118
+913
+6% +$59K 0.08% 234
2025
Q3
$956K Buy
14,205
+2,804
+25% +$222K 0.08% 264
2025
Q2
$995K Sell
11,401
-3,870
-25% -$303K 0.26% 112
2025
Q1
$1.04M Sell
15,271
-13,372
-47% -$1.09M 0.31% 90
2024
Q4
$2.23M Buy
+28,643
New +$2.12M 0.92% 34

Other funds holding DXCM

Tema ETFs's DXCM Position: Q3 2026 in Review

Tema ETFs increased its DexCom (DXCM) stake by 2.4% in Q3 2026, buying an estimated $42.6K and bringing the position to 22,176 shares worth $1.91M. The position accounts for 0.07% of the portfolio, ranked #193.

Tema ETFs first reported a position in DXCM in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.23M in Q4 2024. 138 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Tema ETFs held 22,176 shares of DexCom worth $1.91M as of Q3 2026.
  • Tema ETFs bought 512 DexCom shares in Q3 2026, an estimated $42.6K.
  • DexCom made up 0.07% of Tema ETFs's portfolio in Q3 2026, its #193 holding.
  • Tema ETFs first reported a position in DexCom in Q4 2024 and has held it in 8 quarters since.
  • Tema ETFs's DexCom position peaked at $2.23M in Q4 2024.
  • 138 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.